Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: December 12, 2009
Researchers Find New Drug To Shrink Breast Cancer Tumors
December 12, 2009Boston (SmartAboutHealth) - Researchers have discovered a new antibody drug that has the ability to shrink breast cancer tumors that other drugs have failed to impact.
The study was carried out by researcher Dr. Ian Krop and colleagues at the Dana Farber Cancer Institute.
What they discovered is that a hybrid drug, T-DM1, was able to shrink or at least stop the growth of HER2-positive breast cancer tumors.
The drug is a combination of the antibody tratuzumab and the drug DM1, which has the ability to kill breast cancer cells.
The way in which the drug works is pretty remarkable, as it has the ability to cling onto and attack only breast cancer cells, not the healthy cells in the body.
The antibody can work in conjunction with chemotherapy, allowing the chemotherapy to work while not harming the rest of the body.
During the study, they found that the drug was effective in treating 40% of women who have the HER2-positive breast cancers.
The tumors were shrunk by a margin of 30% or more when it was used.
The drug was also found to stabilize the breast cancer tumors at a high rate as well.
The new drug was presented at the 32nd annual CTRC-AACR San Antonio Breast Cancer Symposium.
Archive issues: (47)
Archive list: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 [16]
October 17, 2011 | Sen. Grassley Seeks FDA Scrutiny of Paxil and Suicide RiskWASHINGTON, June 12, 2008 Senator Chuck Grassley has asked the Food and Drug Administration to carefully scrutinize information it received from drug maker GlaxoSmithKline about the anxiety disorder drug Paxil, based on the contents of a newly available report about the drug's risk for suicide among adults. Grassley also asked the FDA to review findings released earlier this year by the British drug-safety agency which charged that the drug maker has known ...
September 21, 2009 | Topical cream studied for erectile dysfunctionScientists from Albert Einstein College of Medicine of Yeshiva University are working on a cream to rub on and treat erectile dysfunction (ED). The cream could prove to be safer than oral medications used to deliver nitric oxide to the cells that improves blood flow to treat impotency. Using encapsulated nanoparticles, the scientists have found a way to deliver nitric oxide and prescription drugs that penetrate the tissues to treat erectile dysfunction that affects ...
Related articles:
About mens health risks
Mortality rates for all of the 15 leading causes of death for the total population are higher for males than females in America. Men die almost seven years earlier than women. Men are more likely to suffer from chronic illnesses, to suffer a traumatic brain injury, and to die from acquired immune deficiency syndrome (AIDS). Men are less likely to exercise and are more likely to be overweight. They are also less likely to take nutritional supplements, such as vitamins, and to spend time taking care of themselves. Some argue that this ...Section: Mens health risks
Causes
The cause of IC/PBS is unknown, though several theories have been put forward (these include autoimmune, neurologic, allergic and genetic). Regardless of the origin, it is clear that the majority of IC/PBS patients struggle with a damaged urothelium, or bladder lining. When the surface glycosaminoglycan (GAG) layer is damaged (via a urinary tract ...Section: Interstitial cystitis
Diagnosis
Diagnosis has been greatly simplified in recent years with the development of two new methodologies. The Pelvic Pain Urgency/Frequency (PUF) Patient Survey, created by C. Lowell Parsons, is a short questionnaire that will help doctors identify if pelvic pain could be coming from the bladder. The KCl test, also known as the potassium sensitivity test, uses a mild potassium solution to test the integrity of the bladder wall. Though the latter is not specific for IC/PBS, it has been determined to be ...Section: Interstitial cystitis